Song Hong-tao, Qin Yu, Yao Guo-dong, Tian Zhen-nan, Fu Song-bin, Geng Jing-shu
Department of Pathology, The Affiliated Tumor Hospital of Harbin Medical University, Harbin 150040, China.
Department of Medical Genetics, Harbin Medical University, Harbin 150086, China.
Mediators Inflamm. 2014;2014:287381. doi: 10.1155/2014/287381. Epub 2014 Apr 16.
To investigate the role of AEG-1 in glycolysis and tumorigenesis, we construct myc-AEG-1 expression vector and demonstrate a novel mechanism that AEG-1 may increase the activity of AMPK by Thr172 phosphorylation. The higher expression levels of AEG-1 in colorectal carcinoma cells were found but showed significant difference in different cell lines. To study the role of AEG-1 in colorectal cells, myc-AEG-1 vector was constructed and transfected into NCM460 colonic epithelial cells. We observed consistent increasing of glucose consumption and lactate production, typical features of anaerobic glycolysis, suggesting that AEG-1 may promote anaerobic glycolysis. Moreover, we noted that AMPK phosphorylation at Thr172 as well as pPFK2 (Ser466) was increased in NCM460 cells overexpressing AEG-1. Compound C may block AMPK and PFK2 phosphorylation in both control and AEG-1-overexpressed cells and decrease the glucose consumption and lactate production. The present findings indicated that reduced AEG-1 protein levels by RNAi may decrease the glucose consumption and lactate production in HCT116 colorectal carcinoma cells. The present identified AEG-1/AMPK/PFK2 glycolysis cascade may be essential to cell proliferation and tumor growth. The present results may provide us with a mechanistic insight into novel targets controlled by AEG-1, and the components in the AEG-1/AMPK/PFK2 glycolysis process may be targeted for the clinical treatment of cancer.
为了研究AEG-1在糖酵解和肿瘤发生中的作用,我们构建了myc-AEG-1表达载体,并证明了一种新机制,即AEG-1可能通过苏氨酸172磷酸化增加AMPK的活性。在结肠癌细胞中发现AEG-1表达水平较高,但在不同细胞系中存在显著差异。为了研究AEG-1在结肠细胞中的作用,构建了myc-AEG-1载体并将其转染到NCM460结肠上皮细胞中。我们观察到葡萄糖消耗和乳酸生成持续增加,这是无氧糖酵解的典型特征,表明AEG-1可能促进无氧糖酵解。此外,我们注意到在过表达AEG-1的NCM460细胞中,苏氨酸172处的AMPK磷酸化以及pPFK2(丝氨酸466)增加。化合物C可能会阻断对照细胞和过表达AEG-1的细胞中的AMPK和PFK2磷酸化,并降低葡萄糖消耗和乳酸生成。目前的研究结果表明,RNAi降低AEG-1蛋白水平可能会降低HCT116结肠癌细胞中的葡萄糖消耗和乳酸生成。目前确定的AEG-1/AMPK/PFK2糖酵解级联可能对细胞增殖和肿瘤生长至关重要。目前的结果可能为我们提供对AEG-1控制的新靶点的机制性见解,并且AEG-1/AMPK/PFK2糖酵解过程中的成分可能成为癌症临床治疗的靶点。